Stay updated on Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial
Sign up to get notified when there's something new on the Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial page.

Latest updates to the Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial page
- Check5 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check12 days agoChange DetectedA banner announces NIH’s website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedAdds sponsor and trial information blocks (Merck Clinical Trials Information and Merck Sharp & Dohme LLC), IPD sharing details with URLs, and a Publications section referencing the Lancet Respir Med paper; includes access to the Study Protocol and Statistical Analysis Plan and expanded MeSH keywords and related terms.SummaryDifference98%

- Check47 days agoChange DetectedThe study record page now shows a 403 Forbidden error instead of the study details, blocking access to core trial information. The new page displays the 403 header and site chrome, indicating a site-level access issue rather than the expected content.SummaryDifference18%

Stay in the know with updates to Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial page.